Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 316-322

  Beygui, Farzin ^a   Varnous, Shaida ^a   Montalescot, Gilles ^a   Fernandez, Flor ^a   Collet, Jean Philippe ^a   Leprince, Pascal ^a   Le Feuvre, Claude ^a   Pavie, Alain ^a   Komajda, Michel ^a   Metzger, Jean Philippe ^a   Gandjbakhch, Iradj ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

bare metal stent; coronary artery disease; drug eluting stent; heart transplantation; left ventricular function; outcome; restenosis

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL RATE;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77349091338     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.08.020     Document Type: Article

References (27)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
2. Syeda B., Roedler S., Schukro C., et al. Transplant coronary artery disease: incidence, progression and interventional revascularization. Int J Cardiol 104 (2005) 269-274
3. Aranda J.M., Pauly D.F., Kerensky R.A., et al. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience. J Heart Lung Transplant 21 (2002) 860-866
4. Schnetzler B., Drobinski G., Dorent R., et al. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 19 (2000) 557-565
5. Benza R.L., Zoghbi G.J., Tallaj J., et al. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coll Cardiol 43 (2004) 1973-1981
6. Simpson L., Lee E.K., Hott B.J., et al. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant 24 (2005) 1211-1217
7. Bader F.M., Kfoury A.G., Gilbert E.M., et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 25 (2006) 298-301
8. Jonas M., Fang J.C., Wang J.C., et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol 48 (2006) 453-461
9. Tanaka K., Li H., Curran P.J., et al. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol 97 (2006) 1192-1197
10. Jain S.P., Ramee S.R., White C.J., et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol 32 (1998) 1636-1640
11. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
12. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
13. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
14. Rahmani M., Cruz R.P., Granville D.J., et al. Allograft vasculopathy versus atherosclerosis. Circ Res 99 (2006) 801-815
15. Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110 (2004) 2694-2700
16. Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108 (2003) 48-53
17. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
18. Waksman R., Ajani A.E., Pichard A.D., et al. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol 44 (2004) 1386-1392
19. Rodriguez A.E., Granada J.F., Rodriguez-Alemparte M., et al. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study. J Am Coll Cardiol 47 (2006) 1522-1529
20. Wellnhofer E., Hiemann N.E., Hug J., et al. A decade of percutaneous coronary interventions in cardiac transplant recipients: a monocentric study in 160 patients. J Heart Lung Transplant 27 (2008) 17-25
21. Kastrati A., Schomig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
22. Kimura T., Abe K., Shizuta S., et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105 (2002) 2986-2991
23. Erinc K., Yamani M.H., Starling R.C., et al. The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. J Heart Lung Transplant 24 (2005) 1033-1038
24. Braith R.W., Mills R.M., Wilcox C.S., et al. High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients. J Am Coll Cardiol 41 (2003) 426-432
25. Bunke M., and Ganzel B. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. J Heart Lung Transplant 11 (1992) 1194-1199
26. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
27. Barbir M., Lazem F., Banner N., et al. The prognostic significance of non-invasive cardiac tests in heart transplant recipients. Eur Heart J 18 (1997) 692-696